Brief Psychotherapy Research New York City, NY - 10003

Brief Psychotherapy Research is categorized under Psychiatric Hospitals in New York City, NY .

Brief Psychotherapy Research was established in 0, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Psychiatric Hospitals business, which does work in the B2C market, and is classified as a Psychiatric Hospitals, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Chris Muran, Office Manager at the company’s single location by writing to 317 East 17th St, New York City, New York NY 10003 or by phoning (212) 420-3819. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Brief Psychotherapy Research
Contact Person: Chris Muran, Office Manager
Address: 317 East 17th St, New York City, New York 10003
Phone Number: (212) 420-3819
Annual Revenue (USD): $2.500.000 to $4.999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Psychiatric Hospitals
SIC Code: 8063
NAICS Code: 6211110
Share This Business:

Brief Psychotherapy Research was started in 0 to provide professional Psychiatric Hospitals under the SIC code 8063 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Chris Muran, Office Manager for inquiries that concern Brief Psychotherapy Research by calling the company number (212) 420-3819, as your correspondence is most welcome. Additionally, the physical location of the single location of Brief Psychotherapy Research can be found at the coordinates 40.73396,-73.98272 as well as the street address 317 East 17th St in New York City, New York 10003.

For its online presence, you may visit Brief Psychotherapy Research’s website at and engage with its social media outlets through on Twitter and on Facebook.